Furthermore, CAR-T cells secreting relaxin-2 demonstrated increased efficacy and infiltration in stromal-rich solid tumors by remodeling the tumor microenvironment and reducing fibrosis, ultimately promoting better T-cell migration and antitumor responses (190). The gene discussed is RLN2; the disease is neoplasm.